February 27, 2025 Sensodyne maker Haleon says 2025 revenue growth skewed to second half British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted ...
JPMorgan analyst Celine Pannuti raised the firm’s price target on Haleon (HLN) to 315 GBp from 310 GBp and keeps an Underweight rating on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback